J. Kurebayashi

发表

Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas.

S. Asa, S. Ezzat, T. Nakazawa, 2007, Human pathology.

Cell cycle analysis and expression of cell cycle regulator genes in myeloma cells overexpressing cyclin D1

T. Sugihara, J. Kurebayashi, K. Yata, 2001, British journal of haematology.

Endocrine-resistant breast cancer: Underlying mechanisms and strategies for overcoming resistance

J. Kurebayashi, Junichi Kurebayashi, 2003, Breast cancer.

Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells

N. Kanomata, J. Kurebayashi, T. Moriya, 2017, Breast Cancer.

Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6

M. Kurosumi, K. Tanaka, S. Yamamoto, 1999, British Journal of Cancer.

A randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-months depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer

Y. Ohashi, S. Noguchi, J. Kurebayashi, 2015, Breast Cancer.

Molecular mechanisms of the effects of low concentrations of taxol in anaplastic thyroid cancer cells.

H. Namba, S. Yamashita, J. Kurebayashi, 2004, Endocrinology.

A follow-up study of a randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-month depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer

Y. Ohashi, H. Matsumoto, T. Fujii, 2021, Breast Cancer.

Comparison of quality of life between 2-year and 3-or-more-year administration of leuprorelin acetate every-3-months depot in combination with tamoxifen as adjuvant endocrine treatment in premenopausal patients with endocrine-responsive breast cancer: a randomized controlled trial

Y. Ohashi, S. Noguchi, J. Kurebayashi, 2017, Supportive Care in Cancer.

Adjuvant therapy for premenopausal patients with early breast cancer

J. Kurebayashi, 2008, Current opinion in obstetrics & gynecology.

Current clinical trials of endocrine therapy for breast cancer

J. Kurebayashi, 2007, Breast cancer.

Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group

J. Sakamoto, M. Watatani, T. Taguchi, 2008, Cancer Chemotherapy and Pharmacology.

Semi-quantitative comparison of the differentiation markers and sodium iodide symporter messenger ribonucleic acids in papillary thyroid carcinomas using RT-PCR.

J. Kurebayashi, T. Otsuki, H. Sonoo, 2000, European journal of endocrinology.

The selective tyrosine kinase inhibitor, STI571, inhibits growth of anaplastic thyroid cancer cells.

M. Nakashima, S. Yamashita, J. Kurebayashi, 2003, The Journal of clinical endocrinology and metabolism.

Anti-cancer stem cell activity of the Src inhibitor dasatinib in thyroid cancer cells

N. Kanomata, J. Kurebayashi, T. Moriya, 2017 .

Significance of serum carcinoembryonic antigen and CA 15-3 in monitoring advanced breast cancer patients treated with systemic therapy: A large-scale retrospective study

M. Kurosumi, T. Taguchi, J. Kurebayashi, 2003, Breast cancer.

CD1d- and PJA2-related immune microenvironment differs between invasive breast carcinomas with and without a micropapillary feature

N. Kanomata, J. Kurebayashi, T. Moriya, 2019, BMC Cancer.

Intratumoral Estrogen Concentration and Expression of Estrogen-Induced Genes in Male Breast Carcinoma: Comparison with Female Breast Carcinoma

M. Kurosumi, Takashi Suzuki, H. Sasano, 2013, Hormones and Cancer.

Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.

J. Kurebayashi, H. Sonoo, Shigeru Yamamoto, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

A Case of Rare Matrix-producing Triple-negative Breast Carcinoma for Which Drug Response in a Patient-derived Orthotopic Xenograft Mouse Model Was Correlated With Patient Response

J. Kurebayashi, T. Moriya, Jun Yamamoto, 2021, AntiCancer Research.

[Comparison of whole-body MR imaging and bone scintigraphy in the detection of bone metastases from breast cancer].

M. Fukunaga, T. Tamada, S. Yamamoto, 2000, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: Based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011

T. Ishikawa, Takashi Suzuki, Y. Miyoshi, 2015, Breast Cancer.

Multiplex PCR analysis of apocrine lesions shows frequent PI3K–AKT pathway mutations in both benign and malignant apocrine breast tumors

N. Kanomata, J. Kurebayashi, T. Moriya, 2019, Medical Molecular Morphology.

Significance of serum tumor markers in monitoring advanced breast cancer patients treated with systemic therapy: A prospective study

M. Kurosumi, T. Taguchi, J. Kurebayashi, 2004, Breast cancer.

Serum tumor marker kinetics and the clinical course of patients with advanced breast cancer

J. Kurebayashi, H. Sonoo, 1996, Surgery Today.

Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients.

Kazutaka Nakashima, J. Kurebayashi, H. Sonoo, 2006, Japanese journal of clinical oncology.

Translocation of heparanase into nucleus results in cell differentiation

M. Nakajima, N. Tanaka, J. Kurebayashi, 2007, Cancer science.

Postsurgical oral administration of uracil and tegafur inhibits progression of micrometastasis of human breast cancer cells in nude mice.

A. Fujioka, M. Kurosumi, R. Dickson, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[Tumor markers in breast cancer].

J. Kurebayashi, 2004, Gan to kagaku ryoho. Cancer & chemotherapy.

Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis

S. McLeskey, S. Kharbanda, R. Dickson, 2005, Breast Cancer Research and Treatment.

Estrogen receptors in human myeloma cells.

J. Kurebayashi, K. Yata, T. Otsuki, 2000, Cancer research.

Anti‐HER2‐antibody enhances irradiation‐induced growth inhibition in head and neck carcinoma

J. Kurebayashi, K. Yata, T. Otsuki, 2001, International journal of cancer.

Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model

I. Endo, M. Bouvet, R. Hoffman, 2020, AntiCancer Research.

Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.

K. Tanaka, S. Yamamoto, J. Kurebayashi, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Expression Levels of Estrogen Receptor-α, Estrogen Receptor-β, Coactivators, and Corepressors in Breast Cancer

J. Kurebayashi, T. Otsuki, H. Sonoo, 2000 .

Retrospective Analysis of Predictive Factors for Recurrence After Curatively Resected Papillary Thyroid Carcinoma

J. Kurebayashi, H. Sonoo, Katsuhiro Tanaka, 2005, Surgery Today.

[Evaluation of irinotecan hydrochloride (CPT-11) and trastuzumab combination therapy as salvage treatment in patients with HER2 overexpressing metastatic breast cancer].

Kazutaka Nakashima, J. Kurebayashi, H. Sonoo, 2009, Gan to kagaku ryoho. Cancer & chemotherapy.

[Retrospective study on utility of irinotecan hydrochloride in patients with advanced and recurrent breast cancer].

Kazutaka Nakashima, J. Kurebayashi, H. Sonoo, 2003, Gan to kagaku ryoho. Cancer & chemotherapy.

Regulation of interleukin-6 secretion from breast cancer cells and its clinical implications

J. Kurebayashi, 2000, Breast cancer.

Growth factors in breast cancer: Mitogenesis to transformation

L. Amundadottir, R. Dickson, Michael D. Johnson, 1992, The Journal of Steroid Biochemistry and Molecular Biology.

Analyses of the outcome of locally invasive papillary thyroid carcinomas.

J. Kurebayashi, H. Sonoo, K. Tanaka, 1999, Thyroid : official journal of the American Thyroid Association.

Invasion-inhibiting factor 2-albumin conjugate inhibits invasion and spontaneous metastasis of MKL-4 human breast cancer cells transplanted into female nude mice

M. Kurosumi, R. Dickson, J. Kurebayashi, 1996, Clinical & Experimental Metastasis.

Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesions

N. Kanomata, J. Kurebayashi, A. Tanimoto, 2019, BMC cancer.

Endocrine Therapies for Patients with Recurrent Breast Cancer: Predictive Factors for Responses to First- and Second-Line Endocrine Therapies

J. Kurebayashi, H. Sonoo, M. Toi, 2000, Oncology.

Predictive factors for response to endocrine therapy in patients with recurrent Breast Cancer

J. Kurebayashi, H. Sonoo, 2000, Breast cancer.

The impacts of breast conserving treatment and mastectomy on the quality of life in early-stage breast cancer patients

J. Kurebayashi, H. Sonoo, K. Ichihara, 1995, Breast cancer.

Expression and production of interleukin 10 in human myeloma cell lines

J. Kurebayashi, K. Yata, H. Sakaguchi, 2000, British journal of haematology.

Expression of Vascular Endothelial Growth Factor (VEGF) Family Members in Breast Cancer

J. Kurebayashi, T. Otsuki, H. Sonoo, 1999, Japanese journal of cancer research : Gann.

Clinicopathological significance of Y416Src and Y527Src expression in breast cancer

N. Kanomata, J. Kurebayashi, H. Sonoo, 2011, Journal of Clinical Pathology.

A Case of Adenomatous Goiter Involving Diffuse, Acute, and Painful Thyroid Enlargement after Fine-Needle Aspiration Cytology

J. Kurebayashi, Yutaka Yamamoto, Yoshikazu Koike, 2014, Case reports in endocrinology.

Stereospecific antitumor activity of radicicol oxime derivatives

M. Shimizu, Sreenath V. Sharma, L. Neckers, 2001, Cancer Chemotherapy and Pharmacology.

Interstitial brachytherapy for recurrent breast cancer using a high dose rate lr-192 remote afterloading system: a report of two cases

J. Kurebayashi, H. Sonoo, E. Yoden, 2000, Breast Cancer.

Loss of BRCA1 expression may predict shorter time-to-progression in metastatic breast cancer patients treated with taxanes.

M. Kurosumi, J. Kurebayashi, H. Sonoo, 2006, Anticancer research.

EFFECT OF 1 α-HYDROXYVITAMIN D3 ON 7, 12-DIMETHYLBENZ (A) ANTHRACENE-INDUCED RAT MAMMARY TUMORS

J. Kurebayashi, M. Izuo, Y. Iino, 1989 .

Analysis of Clinical Outcome of Patients with Poorly Differentiated Thyroid Carcinoma

J. Kurebayashi, H. Sonoo, Yutaka Yamamoto, 2011, ISRN endocrinology.

The practice of breast self-examination results in the earlier detection and better clinical course of Japanese women with breast cancer

J. Kurebayashi, H. Sonoo, K. Shimozuma, 2006, Surgery Today.

The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence.

J. Kurebayashi, H. Sonoo, U. Prabhakar, 2009, Thyroid : official journal of the American Thyroid Association.

Comparison of modified radical mastectomy with quadrantectomy, axillary dissection, and radiation therapy in early breast cancer in Japanese Women

J. Kurebayashi, H. Sonoo, K. Miyake, 1995, Breast cancer.

Preclinical rationale for combined use of endocrine therapy and 5-fluorouracil but neither doxorubicin nor paclitaxel in the treatment of endocrine-responsive breast cancer

J. Kurebayashi, J. Uchida, H. Sonoo, 2009, Cancer Chemotherapy and Pharmacology.

Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells

J. Kurebayashi, Y. Sugimoto, T. Oka, 2007, Cancer Chemotherapy and Pharmacology.

Phosphorylated HER3 and FITC-labeled trastuzumab immunohistochemistry in patients with HER2-positive breast cancer treated with adjuvant trastuzumab

N. Kanomata, J. Kurebayashi, T. Moriya, 2018, Medical Molecular Morphology.

Dose-escalation phase I study in metastatic breast cancer patients with combination of paclitaxel and tegafur·uracil.

J. Kurebayashi, H. Sonoo, S. Ohno, 2010, Oncology letters.

Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells

J. Kurebayashi, Yoshikazu Koike, W. Saitoh, 2020, Breast Cancer.

Correction: Preparation of a novel antiserum to aromatase with high affinity and specificity: Its clinicopathological significance on breast cancer tissue

N. Kanomata, J. Kurebayashi, S. Matsuura, 2017, PloS one.

Preparation of a novel antiserum to aromatase with high affinity and specificity: Its clinicopathological significance on breast cancer tissue

N. Kanomata, J. Kurebayashi, S. Matsuura, 2017, PloS one.

Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society

H. Tsuda, M. Kurosumi, T. Ohta, 2010, Breast cancer.

All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1.

J. Kurebayashi, T. Otsuki, M. Uno, 2000, The Journal of clinical endocrinology and metabolism.

A new human breast cancer cell line, KPL-1 secretes tumour-associated antigens and grows rapidly in female athymic nude mice.

M. Kurosumi, J. Kurebayashi, H. Sonoo, 1995, British Journal of Cancer.

CD1d- and PJA2-related immune microenvironment differs between invasive breast carcinomas with and without a micropapillary feature

N. Kanomata, J. Kurebayashi, T. Moriya, 2019, BMC Cancer.

Pattern of RECK CpG methylation as a potential marker for predicting breast cancer prognosis and drug-sensitivity

K. Iwaisako, J. Kurebayashi, M. Toi, 2016, Oncotarget.

Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab

N. Kanomata, J. Kurebayashi, H. Sonoo, 2015, Breast Cancer.

Management of ErbB2-positive Breast Cancer: Insights from Preclinical and Clinical Studies with Lapatinib

Sung-Bae Kim, B. Gril, J. Kurebayashi, 2010, Japanese journal of clinical oncology.

Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model

P. Pandolfi, T. Giordano, A. Fischer, 2015, Oncotarget.

High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families

Yusuke Nakamura, T. Katagiri, Y. Miki, 1998, Journal of Human Genetics.

Additive antitumor effects of gefitinib and imatinib on anaplastic thyroid cancer cells

Yutaka Yamamoto, Masahiko Ikeda, J. Kurebayashi, 2006, Cancer Chemotherapy and Pharmacology.

Aberrantly methylated genes in human papillary thyroid cancer and their association with BRAF/RAS mutation

H. Aburatani, A. Kaneda, J. Kurebayashi, 2013, Front. Genet..

Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect

S. Yamamoto, J. Kurebayashi, T. Otsuki, 1999, British Journal of Cancer.

Antitumor and anticancer stem cell activity of a poly ADP-ribose polymerase inhibitor olaparib in breast cancer cells

N. Kanomata, J. Kurebayashi, H. Sonoo, 2012, Breast Cancer.

Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtype

Mika Watanabe, Takuya Moriya, Naoki Kanomata, 2010, BMC Cancer.

Automated assessment of Ki‐67 in breast cancer: the utility of digital image analysis using virtual triple staining and whole slide imaging

N. Kanomata, A. Hida, Y. Oshiro, 2020, Histopathology.

Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells

N. Kanomata, J. Kurebayashi, Yoshikazu Koike, 2019, Breast Cancer.

Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation.

M. Taniwaki, N. Nakazawa, J. Kurebayashi, 1999, International journal of oncology.

Effect of hypoxia on human seminoma cells.

Y. Jo, J. Kurebayashi, K. Yata, 2002, International journal of oncology.

Medroxyprogesterone acetate decreases secretion of interleukin-6 and parathyroid hormone-related protein in a new anaplastic thyroid cancer cell line, KTC-2.

J. Kurebayashi, T. Otsuki, H. Sonoo, 2003, Thyroid : official journal of the American Thyroid Association.

Nuclear cysteine cathepsin variants in thyroid carcinoma cells

M. Bogyo, J. Kurebayashi, N. Kopitar-Jerala, 2010, Biological chemistry.

A new human breast cancer cell line, KPL-3C, secretes parathyroid hormone-related protein and produces tumours associated with microcalcifications in nude mice.

M. Kurosumi, J. Kurebayashi, H. Sonoo, 1996, British Journal of Cancer.

The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy.

F. Akiyama, S. Masuda, S. Noguchi, 2014, Cancer letters.

MDGF-1: A New Tyrosine Kinase-Associated Growth Factor

R. Dickson, F. Kern, Michael D. Johnson, 1993 .

Resistance to endocrine therapy in breast cancer

J. Kurebayashi, 2005, Cancer Chemotherapy and Pharmacology.

A CASE OF APOCRINE DUCTAL CARCINOMA IN SITU OF THE BREAST WITH AN EXTENSIVE INTRADUCTAL SPREAD FORESEEN BY DYNAMIC MRI OF THE BREAST

Kazutaka Nakashima, J. Kurebayashi, H. Sonoo, 2004 .

Hypoxia Reduces Hormone Responsiveness of Human Breast Cancer Cells

J. Kurebayashi, T. Otsuki, H. Sonoo, 2001, Japanese journal of cancer research : Gann.

Transfected MCF-7 cells as a model for breast cancer progression

S. Kharbanda, R. Dickson, F. Kern, 2004, Breast Cancer Research and Treatment.

Aberrant promoter methylation in overexpression of CITED1 in papillary thyroid cancer.

Y. Hayashi, T. Imai, J. Kurebayashi, 2011, Thyroid : official journal of the American Thyroid Association.

Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone

N. Kanomata, C. Shimizu, H. Tsuda, 2014, Breast Cancer.

Topoisomerase IIalpha-positive and BRCA1-negative phenotype: association with favorable response to epirubicin-based regimens for human breast cancers.

E. Tokunaga, M. Kurosumi, Y. Miyoshi, 2008, Cancer letters.

Expression of Vascular Endothelial Growth Factor Family Messenger RNA in Diseased Thyroid Tissues

J. Kurebayashi, T. Otsuki, H. Sonoo, 2002, Surgery Today.

The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races.

T. Kinoshita, F. Akiyama, M. Kurosumi, 2007, Breast.

A case of euthyroid Graves disease which developed into Graves disease with thyrotoxicosis after subacute thyroiditis

J. Kurebayashi, H. Sonoo, Yutaka Yamamoto, 2009 .

Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo

N. Shikata, J. Kurebayashi, K. Hioki, 1997, Breast Cancer Research and Treatment.

Angiogenesis inhibitorO-(chloroacetyl-carbamoyl) fumagillol (TNP-470) inhibits tumor angiogenesis, growth and spontaneous metastasis of MKL- 4 human breast cancer cells in female athymic nude mice

M. Kurosumi, R. Dickson, J. Kurebayashi, 1994 .

Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells

K. Tanaka, J. Kurebayashi, T. Otsuki, 2004, British Journal of Cancer.

Possible treatment strategies for triple-negative breast cancer on the basis of molecular characteristics

J. Kurebayashi, 2009, Breast cancer.

Parathyroid hormone-related protein secretion is inhibited by oestradiol and stimulated by antioestrogens in KPL-3C human breast cancer cells.

J. Kurebayashi, H. Sonoo, 1997, British Journal of Cancer.

Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.

S. McLeskey, R. Dickson, F. Kern, 1993, Cancer research.

Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.

N. Tanaka, J. Kurebayashi, M. Haisa, 2009, International journal of oncology.

TRANSFORMATION TO UNDIFFERENTIATED FROM DIFFERENTIATED THYROID CANCER ASSOCIATED WITH REMARKABLE LEUKOCYTOSIS AND HYPERCALCEMIA-REPORT OF A CASE-

J. Kurebayashi, H. Sonoo, Y. Mikami, 2000 .

Predictive factors for anthracycline-based chemotherapy for human breast cancer

E. Tokunaga, M. Kurosumi, Y. Miyoshi, 2010, Breast cancer.

Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancers

E. Tokunaga, M. Kurosumi, Y. Miyoshi, 2008, Journal of Cancer Research and Clinical Oncology.

Cost analysis of leuprorelin acetate in Japanese pre-menopausal breast-cancer patients: comparison between 6-month and 3-month depot formulations

J. Kurebayashi, K. Iwasaki, S. Hiroi, 2017, Journal of medical economics.

Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2

H. Doihara, N. Shimizu, M. Kurosumi, 1999, British Journal of Cancer.

Biological and clinical significance of her2 overexpression in Breast Cancer

J. Kurebayashi, 2001, Breast cancer.

Epigenetically controlled fibroblast growth factor receptor 2 signaling imposes on the RAS/BRAF/mitogen-activated protein kinase pathway to modulate thyroid cancer progression.

Wei Liu, S. Asa, S. Ezzat, 2007, Cancer research.

A Radicicol Derivative, KF58333, Inhibits Expression of Hypoxia‐inducible Factor‐1α and Vascular Endothelial Growth Factor, Angiogenesis and Growth of Human Breast Cancer Xenografts

M. Kurosumi, S. Soga, S. Akinaga, 2001, Japanese journal of cancer research : Gann.

Dietary effects of fatty acids on growth and metastasis of KPL-1 human breast cancer cells in vivo and in vitro.

J. Kurebayashi, K. Hioki, A. Tsubura, 1998, Anticancer research.

Metastatic Papillary Thyroid Carcinoma of the Submandibular Lymph Nodes with Extensive Squamous Metaplasia: Report of a Case

J. Kurebayashi, H. Sonoo, Y. Mikami, 2003, Surgery Today.

Characterization of the functional domains and quantification in the cells of a steroid receptor-binding protein, SRB-RGS

S. Inoue, J. Kurebayashi, M. Muramatsu, 2011 .

Analysis of factors associated with quality of life in breast cancer patients after surgery

J. Kurebayashi, H. Sonoo, K. Ichihara, 1994, Breast cancer.

Interleukin 10 abolishes the growth inhibitory effects of all‐trans retinoic acid on human myeloma cells

Y. Matsuo, T. Sugihara, J. Kurebayashi, 2002, British journal of haematology.

Molecular morphological approach to the pathological study of development and advancement of human breast cancer

N. Kanomata, H. Sasano, N. Ohuchi, 2010, Medical Molecular Morphology.

Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ.

S. McLeskey, R. Dickson, F. Kern, 1993, Cancer research.

A CASE OF LOCALLY ADVANCED BREAST CARCINOMA 25 YEARS AFTER AN AUGMENTATION MAMMAPLASTY

J. Kurebayashi, H. Matsumoto, H. Shinkai, 1989 .

Efficacy and safety of leuprorelin acetate 6-month depot, TAP-144-SR (6M), in combination with tamoxifen in postoperative, premenopausal patients with hormone receptor-positive breast cancer: a phase III, randomized, open-label, parallel-group comparative study

J. Kurebayashi, T. Toyama, Tsukasa Fujimoto, 2016, Breast Cancer.

A Pure Antiestrogen, ICI 182,780, Stimulates the Growth of Tamoxifen-Resistant KPL-1 Human Breast Cancer Cells in vivo but not in vitro

M. Kurosumi, S. Akinaga, J. Kurebayashi, 1998, Oncology.

Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer.

Y. Higashi, K. Suemasu, J. Kurebayashi, 1990, Japanese Journal of Clinical Oncology.

Inhibition of HER1 signaling pathway enhances antitumor effect of endocrine therapy in breast cancer

J. Kurebayashi, H. Sonoo, Yutaka Yamamoto, 2004, Breast cancer.

Basaloid type adenoid cystic carcinoma of the breast

T. Manabe, M. Hirokawa, J. Kurebayashi, 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Clinicopathologic and prognostic features of triple-negative breast cancer analyzed in registration data of the Japanese Breast Cancer Society, 11705 cases.

H. Tsuda, M. Kurosumi, K. Miyamoto, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Current status and controversial issues concerning endocrine therapy for patients with recurrent breast cancer in Japan

J. Kurebayashi, H. Sonoo, M. Toi, 1999, Breast cancer.

Anti‐cancer stem cell activity of a hedgehog inhibitor GANT61 in estrogen receptor‐positive breast cancer cells

N. Kanomata, J. Kurebayashi, T. Moriya, 2017, Cancer science.

The cell cycle profile test is a prognostic indicator for breast cancer patients treated with postoperative 5-fluorouracil-based chemotherapy.

N. Kanomata, S. Noguchi, J. Kurebayashi, 2011, Japanese journal of clinical oncology.

Comprehensive immunohistochemical analyses on expression levels of hedgehog signaling molecules in breast cancers

N. Kanomata, J. Kurebayashi, Yoshikazu Koike, 2018, Breast Cancer.

Paradoxical Hormone Responses of KPL-1 Breast Cancer Cells in vivo: A Significant Role of Angiogenesis in Tumor Growth

M. Kurosumi, J. Kurebayashi, T. Otsuki, 2000, Oncology.

Long-term outcome of hypofractionated radiotherapy to the whole breast of Japanese women after breast-conserving surgery

J. Kurebayashi, H. Sonoo, R. Sasaki, 2012, Breast Cancer.

Changes of expression level of the differentiation markers in papillary thyroid carcinoma under thyrotropin suppression therapy in vivo immunohistochemical detection of thyroglobulin, thyroid peroxidase, and thyrotropin receptor

J. Kurebayashi, H. Sonoo, Katsuhiro Tanaka, 2000, Journal of surgical oncology.

[A pilot study of the reduced effects of adverse events caused by oral morphine and oxycodone after rotating to fentanyl patch in patients with metastatic breast cancer].

Kazutaka Nakashima, J. Kurebayashi, H. Sonoo, 2012, Gan to kagaku ryoho. Cancer & chemotherapy.

Antitumor effects of Marginisporum crassissimum (Rhodophyceae), a marine red alga.

J. Kurebayashi, S. Imai, J. Morimoto, 2001, Cancer letters.

[Endocrine therapy for advanced or recurrent breast cancer].

J. Kurebayashi, H. Sonoo, 2001, Gan to kagaku ryoho. Cancer & chemotherapy.

[A case of paclitaxel and trastuzumab-resistant recurrent breast cancer with liver metastasis responding to S-1].

Kazutaka Nakashima, J. Kurebayashi, H. Sonoo, 2008, Gan to kagaku ryoho. Cancer & chemotherapy.

[Biomarkers in breast cancer].

J. Kurebayashi, 2004, Gan to kagaku ryoho. Cancer & chemotherapy.

Preoperative dynamic lymphoscintigraphy predicts sentinel lymph node metastasis in patients with early breast cancer

M. Fukunaga, Kazutaka Nakashima, J. Kurebayashi, 2010, Breast cancer.

Expression Levels of Estrogen Receptor-α, Estrogen Receptor-β, Coactivators, and Corepressors in Breast Cancer

J. Kurebayashi, T. Otsuki, H. Sonoo, 2000 .

Timing of surgery in relation to the menstrual cycle and its influence on the survival of Japanese women with operable breast cancer

J. Kurebayashi, H. Sonoo, K. Shimozuma, 1995, Surgery Today.

Antitumor and anticancer stem cell activities of eribulin mesylate and antiestrogens in breast cancer cells

Takuya Moriya, Naoki Kanomata, N. Kanomata, 2016, Breast Cancer.

[Ten cases of an apocrine carcinoma of the breast and a review of cases in the Japanese literature].

M. Kurosumi, J. Kurebayashi, M. Izuo, 1990, Gan no rinsho. Japan journal of cancer clinics.